How to start prophylaxis

Area of Science:

• Hematology
• Pediatric Medicine
• Vascular Access

Background:

• Severe hemophilia requires early intervention to prevent debilitating bleeding.
• Primary prophylaxis is the standard of care, but venous access can be challenging.
• Peripheral vein injections offer a potential alternative to central venous access for prophylaxis.

Purpose of the Study:

• To evaluate the efficacy and safety of initiating primary prophylaxis via peripheral vein injections in boys with severe hemophilia.
• To assess bleeding symptoms before and during the transition to home-based prophylaxis.
• To determine the feasibility of peripheral venous access for long-term hemophilia treatment.

Main Methods:

• A cohort study of 47 boys with severe hemophilia (born 1987-2000) was conducted.
• Data collected on bleeding events prior to and during prophylaxis initiation.
• Mean age at prophylaxis start was 16 months; mean age for full prophylaxis was 30 months.

Main Results:

• Primary prophylaxis via peripheral vein injections was successful in 83% of patients.
• Despite early initiation, 59% received clotting factor concentrate before prophylaxis.
• 72% experienced no joint or muscle bleeding during prophylaxis transition.
• No cerebral bleeding occurred; one patient presented with epidural bleeding.

Conclusions:

• Gradual introduction of primary prophylaxis through peripheral vein injections is feasible and effective for most boys with severe hemophilia.
• Early prophylaxis initiation via peripheral veins can significantly reduce bleeding complications.
• Peripheral venous access is a viable option for home treatment in pediatric hemophilia management.